Abstract
Arthritis, a diverse spectrum of joint disorders, is characterized by chronic pain and inflammation. Osteoarthritis (OA), the most prevalent form, leads to disabling pain, functional limitations, and reduced mobility. Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for managing OA pain, with ketoprofen recognized as one of the effective options. However, oral administration of ketoprofen may cause gastrointestinal irritation. Addressing this issue, Transdermal Drug Delivery Systems (TDDS) emerge as a promising alternative route of administration. TDDS facilitates delivery of various drugs through the skin without undergoing first-pass metabolism. Recent studies have centered on enhancing ketoprofen’s transdermal delivery, particularly focusing on different methods (such as patches, gels, electroporation technology, and stratum corneum bypass methods), with microneedles emerging as a promising approach for delivering anti-inflammatory drugs through transdermal routes. This review aims to explore recent advancements in transdermal drug delivery systems for managing OA. The utilization of transdermal ketoprofen presents innovative opportunities for future research and development in novel drug delivery systems.
References
Atzeni, F., Masala, I. F., Bagnasco, M., Lanata, L., Mantelli, F., & Sarzi-Puttini, P. (2021). Comparison of efficacy of ketoprofen and ibuprofen in treating pain in patients with rheumatoid arthritis: A systematic review and meta-analysis. Pain and Therapy, 10(1), 577–588. https://doi.org/10.1007/s40122-021-00250-3
Bhargava, D., Thomas, S., & Beena, S. (2019). Comparison between efficacy of transdermal ketoprofen and diclofenac patch in patients undergoing therapeutic extraction—A randomized prospective split mouth study. Journal of Oral and Maxillofacial Surgery, 77(10), 1998–2003. https://doi.org/10.1016/j.joms.2019.04.007
Cagnie B, Vinck E, Rimbaut S, Vanderstraeten G. Phonophoresis versus topical application of ketoprofen: comparison between tissue and plasma levels. Phys Ther. 2003 Aug;83(8):707-12. PMID: 12882611.
Chourasia, M. K., Kang, L., & Chan, S. Y. (2011). Nanosized ethosomes bearing ketoprofen for improved transdermal delivery. Results in Pharma Sciences, 1(1), 60–67. https://doi.org/10.1016/j.rinphs.2011.10.002
Conaghan, P. G., Dickson, J., Bolten, W., Cevc, G., & Rother, M. (2013). A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis. Rheumatology. Volume 52. Issue 7. July 2013. Pages 1303–1312.https://doi.org/10.1093/rheumatology/ket133
Ghlichloo I, Gerriets V. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs). 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 31613522.
Heo, S. K., Cho, J., Cheon, J. W., Choi, M. K., Im, D. S., Kim, J. J., Choi, Y. G., Jeon, D. Y., Chung, S. J., Shim, C. K., & Kim, D. D. (2008). Pharmacokinetics and pharmacodynamics of ketoprofen plasters. Biopharmaceutics & drug disposition, 29(1), 37–44. https://doi.org/10.1002/bdd.587
Herwadkar, A., Sachdeva, V., Taylor, L. F., Silver, H., & Banga, A. K. (2012). Low frequency sonophoresis mediated transdermal and intradermal delivery of ketoprofen. International Journal of Pharmaceutics, 423(2),289–296.https://doi.org/10.1016/j.ijpharm.2011.11.041
Jadhav, P., Sinha, R., Uppada, U. K., Tiwari, P. K., & Subramanya Kumar, A. V. S. S. (2018). Pre-emptive diclofenac versus ketoprofen as a transdermal drug delivery system: How they face. Journal of Maxillofacial and Oral Surgery, 17(4), 488–494. https://doi.org/10.1007/s12663-017-1048-1
Jang, S., Lee, K., & Ju, J. H. (2021). Recent updates of diagnosis, pathophysiology, and treatment on osteoarthritis of the knee. International Journal of Molecular Sciences, 22(5), 1–15. https://doi.org/10.3390/ijms22052619
Kheradmandnia, S., Vasheghani-Farahani, E., Nosrati, M., & Atyabi, F. (2010). Preparation and characterization of ketoprofen-loaded solid lipid nanoparticles made from beeswax and carnauba wax. Nanomedicine: Nanotechnology, Biology, and Medicine, 6(6), 753–759. https://doi.org/10.1016/j.nano.2010.06.003
Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., Gellar, K., Harvey, W. F., Hawker, G., Herzig, E., Kwoh, C. K., Nelson, A. E., Samuels, J., Scanzello, C., White, D., Wise, B., … Reston, J. (2020). 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Care & Research, 72(2), 149–162. https://doi.org/10.1002/acr.24131
Kulkarni, R. V., & Sa, B. (2009). Electroresponsive polyacrylamide-grafted-xanthan hydrogels for drug delivery. Journal of Bioactive and Compatible Polymers, 24(4), 368–384. https://doi.org/10.1177/0883911509104475
Liu, X. C., & Lin, L. (2021). Controlling the Self-assembly of metal-cages organic and transdermal drug delivery. Inorganic Chemistry Communications, 129(May), 108660. https://doi.org/10.1016/j.inoche.2021.108660
Lobo, S., & Yan, G. (2018). Improving the direct penetration into tissues underneath the skin with iontophoresis delivery of a ketoprofen cationic prodrug. International Journal of Pharmaceutics, 535(1–2), 228–236. https://doi.org/10.1016/j.ijpharm.2017.10.061
Long, H., Liu, Q., Yin, H., Wang, K., Diao, N., Zhang, Y., Lin, J., & Guo, A. (2022). Prevalence trends of site-specific osteoarthritis from 1990 to 2019: Findings from the global burden of disease study 2019. Arthritis and Rheumatology, 74(7), 1172–1183. https://doi.org/10.1002/art.42089
Magni, A., Agostoni, P., Bonezzi, C., Massazza, G., Menè, P., Savarino, V., & Fornasari, D. (2021). Management of osteoarthritis: Expert opinion on NSAIDs. Pain and Therapy, 10(2), 783–808. https://doi.org/10.1007/s40122-021-00260-1
Manikkath, J., Manikkath, A., Shavi, G. V., Bhat, K., & Mutalik, S. (2017). Low frequency ultrasound and PAMAM dendrimer facilitated transdermal delivery of ketoprofen. Journal of Drug Delivery Science and Technology, 41, 334–343. https://doi.org/10.1016/j.jddst.2017.07.021
Panus, P. C., Campbell, J., Kulkarni, S. B., Herrick, R. T., Ravis, W. R., & Banga, A. K. (1997). Transdermal iontophoretic delivery of ketoprofen through human cadaver skin and in humans. Journal of Controlled Release, 44(2–3), 113–121. https://doi.org/10.1016/S0168-3659(96)01509-X
Paolino, D., Ventura, C. A., Nisticò, S., Puglisi, G., & Fresta, M. (2002). Lecithin microemulsions for the topical administration of ketoprofen: Percutaneous adsorption through human skin and in vivo human skin tolerability. International Journal of Pharmaceutics, 244(1–2),21–31.https://doi.org/10.1016/S0378-5173(02)00295-8
Puglia, C., Blasi, P., Rizza, L., Schoubben, A., Bonina, F., Rossi, C., & Ricci, M. (2008). Lipid nanoparticles for prolonged topical delivery: An in vitro and in vivo investigation. International Journal of Pharmaceutics, 357(1–2),295–304.https://doi.org/10.1016/j.ijpharm.2008.01.045
Ramadon, D., McCrudden, M. T. C., Courtenay, A. J., & Donnelly, R. F. (2022). Enhancement strategies for transdermal drug delivery systems: current trends and applications. Drug Delivery and Translational Research, 12(4), 758–791. https://doi.org/10.1007/s13346-021-00909-6
Ramadon, D., Ulayya, F., Qur’ani, A. S., Iskandarsyah, I., Harahap, Y., Anjani, Q. K., Aileen, V., Hartrianti, P., & Donnelly, R. F. (2023). Combination of dissolving microneedles with nanosuspension and co-grinding for transdermal delivery of ketoprofen. Pharmaceuticals (Basel, Switzerland), 16(3), 378. https://doi.org/10.3390/ph16030378
Rannou, F., Pelletier, J. P., & Martel-Pelletier, J. (2016). Efficacy and safety of topical NSAIDs in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Seminars in Arthritis and Rheumatism, 45(4), S18–S21. https://doi.org/10.1016/j.semarthrit.2015.11.007
Rençber, S., Karavana, S. Y., & Özyazici, M. (2009). Bioavailability File : KETOPROFEN. 203–216.
Rother, M., Lavins, B. J., Kneer, W., Lehnhardt, K., Seidel, E. J., & Mazgareanu, S. (2007). Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial. Annals of The Rheumatic Diseases, 66(9), 1178–1183. https://doi.org/10.1136/ard.2006.065128
Rother, M., Seidel, E. J., Clarkson, P. M., Mazgareanu, S., Vierl, U., & Rother, I. (2009). Efficacy of epicutaneous Diractin® (ketoprofen in Transfersome® gel) for the treatment of pain related to eccentric muscle contractions. Drug Design, Development and Therapy, 3, 143–149. https://doi.org/10.2147/dddt.s5501
Salamanca, C. H., Barrera-Ocampo, A., Lasso, J. C., Camacho, N., & Yarce, C. J. (2018). Franz diffusion cell approach for pre-formulation characterisation of ketoprofen semi-solid dosage forms. Pharmaceutics, 10(3), 1–11. https://doi.org/10.3390/pharmaceutics10030148
Sardana, V., Burzynski, J., & Zalzal, P. (2017). Safety and efficacy of topical ketoprofen in transfersome gel in knee osteoarthritis: A systematic review. Musculoskeletal Care, 15(2), 114–121. https://doi.org/10.1002/msc.1163
Sarzi- Puttini, P., Atzeni, F., Lanata, L., Bagnasco, M., Colombo, M., Fischer, F., & D’Imporzano, M. (2011). Pain and ketoprofen: what is its role in clinical practice? Reumatismo, 62(3), 172–188. https://doi.org/10.4081/reumatismo.2010.172
So, J. W., Park, H. H., Lee, S. S., Kim, D. C., Shin, S. C., & Cho, C. W. (2009). Effect of microneedle on the pharmacokinetics of ketoprofen from its transdermal formulations. Drug Delivery, 16(1), 52–56. https://doi.org/10.1080/10717540802518082
Swart, H., Breytenbach, J. C., Hadgraft, J., & Du Plessis, J. (2005). Synthesis and transdermal penetration of NSAID glycoside esters. International Journal of Pharmaceutics, 301(1–2), 71–79. https://doi.org/10.1016/j.ijpharm.2005.05.030
Takahashi, A., Suzuki, S., Kawasaki, N., Kubo, W., Miyazaki, S., Loebenberg, R., Bachynsky, J., & Attwood, D. (2002). Percutaneous absorption of non-steroidal anti-inflammatory drugs from in situ gelling xyloglucan formulations in rats. International Journal of Pharmaceutics, 246(1–2), 179–186. https://doi.org/10.1016/S0378-5173(02)00394-0
Tanner, T., & Marks, R. (2008). Delivering drugs by the transdermal route: Review and comment. Skin Research and Technology, 14(3), 249–260. https://doi.org/10.1111/j.1600-0846.2008.00316.x
Wang, Y., Fan, M., Wang, H., You, Y., & Wei, C. (2022). Relative safety and efficacy of topical and oral NSAIDs in the treatment of osteoarthritis: A systematic review and meta-analysis. Medicine (United States), 101(36), E30354. https://doi.org/10.1097/MD.0000000000030354
Wolff, D. G., Christophersen, C., Brown, S. M., & Mulcahey, M. K. (2021). Topical nonsteroidal anti-inflammatory drugs in the treatment of knee osteoarthritis: a systematic review and meta-analysis. Physician and Sportsmedicine, 49(4), 381–391. https://doi.org/10.1080/00913847.2021.1886573
Yu, L., Li, S., Yuan, Y., Dai, Y., & Liu, H. (2006). The delivery of ketoprofen from a system containing ion-exchange fibers. International Journal of Pharmaceutics, 319(1–2),107–113. https://doi.org/10.1016/j.ijpharm.2006.03.039
Recommended Citation
Ramadhani, Dwi Asih; Harahap, Yahdiana; Sagita, Erny; Permata Sari, Kartika Citra Dewi; Andranilla, Rr. Kirana; Trisina, Jessica; Punu, Gabriella Frederika; and Ramadon, Delly
(2024)
"Transdermal Delivery of Ketoprofen for Osteoarthritis Treatment and Management: A Literature Review on Current Progression,"
Pharmaceutical Sciences and Research: Vol. 11:
No.
1, Article 2.
DOI: 10.7454/psr.v11i1.1355
Available at:
https://scholarhub.ui.ac.id/psr/vol11/iss1/2